| Comprehensive genomic characterization of head and neck squamous cell carcinomas TCGA Network Nature 517 (7536), 576–582, 2015 | 3344 | 2015 |
| Characterization of HPV and host genome interactions in primary head and neck cancers M Parfenov, CS Pedamallu, N Gehlenborg, SS Freeman, L Danilova, ... Proceedings of the National Academy of Sciences 111 (43), 15544-15549, 2014 | 430 | 2014 |
| MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway NM Alajez, M Lenarduzzi, E Ito, ABY Hui, W Shi, J Bruce, S Yue, ... Cancer research 71 (6), 2381-2391, 2011 | 334 | 2011 |
| Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy SK Rehman, J Haynes, E Collignon, KR Brown, Y Wang, AML Nixon, ... Cell 184 (1), 226-242. e21, 2021 | 329 | 2021 |
| Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98 NM Alajez, W Shi, ABY Hui, J Bruce, M Lenarduzzi, E Ito, S Yue, ... Cell death & disease 1 (10), e85-e85, 2010 | 186 | 2010 |
| HPV associated head and neck cancer T Spence, J Bruce, KW Yip, FF Liu Cancers 8 (8), 75, 2016 | 172 | 2016 |
| Nasopharyngeal cancer: molecular landscape JP Bruce, K Yip, SV Bratman, E Ito, FF Liu Journal of Clinical Oncology 33 (29), 3346-3355, 2015 | 172 | 2015 |
| Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial S Lheureux, MC Cristea, JP Bruce, S Garg, M Cabanero, ... The Lancet 397 (10271), 281-292, 2021 | 162 | 2021 |
| miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1 X Huang, S Taeb, S Jahangiri, U Emmenegger, E Tran, J Bruce, A Mesci, ... Cancer research 73 (23), 6972-6986, 2013 | 149 | 2013 |
| Tumor‐derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery S Principe, ABY Hui, J Bruce, A Sinha, FF Liu, T Kislinger Proteomics 13 (10-11), 1608-1623, 2013 | 145 | 2013 |
| The genomic landscape of schwannoma S Agnihotri, S Jalali, MR Wilson, A Danesh, M Li, G Klironomos, ... Nature genetics 48 (11), 1339-1348, 2016 | 140 | 2016 |
| Translational genomics of nasopharyngeal cancer CM Tsang, VWY Lui, JP Bruce, TJ Pugh, KW Lo Seminars in cancer biology 61, 84-100, 2020 | 131 | 2020 |
| The microRNA-218~ Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer R Kogo, C How, N Chaudary, J Bruce, W Shi, RP Hill, P Zahedi, KW Yip, ... Oncotarget 6 (2), 1090, 2015 | 127 | 2015 |
| Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma ABY Hui, A Lin, W Xu, L Waldron, B Perez-Ordonez, I Weinreb, W Shi, ... Clinical cancer research 19 (8), 2154-2162, 2013 | 124 | 2013 |
| Human papillomavirus genotype association with survival in head and neck squamous cell carcinoma SV Bratman, JP Bruce, B O’Sullivan, TJ Pugh, W Xu, KW Yip, FF Liu JAMA oncology 2 (6), 823-826, 2016 | 118 | 2016 |
| Fructose and carbonyl metabolites as endogenous toxins O Lee, WR Bruce, Q Dong, J Bruce, R Mehta, PJ O’Brien Chemico-biological interactions 178 (1-3), 332-339, 2009 | 118 | 2009 |
| Significance of dysregulated metadherin and microRNA-375 in head and neck cancer ABY Hui, JP Bruce, NM Alajez, W Shi, S Yue, B Perez-Ordonez, W Xu, ... Clinical Cancer Research 17 (24), 7539-7550, 2011 | 112 | 2011 |
| EVOLVE: a multicenter open-label single-arm clinical and translational phase II trial of cediranib plus olaparib for ovarian cancer after PARP inhibition progression S Lheureux, A Oaknin, S Garg, JP Bruce, A Madariaga, NC Dhani, ... Clinical Cancer Research 26 (16), 4206-4215, 2020 | 99 | 2020 |
| Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas S Agnihotri, S Suppiah, PD Tonge, S Jalali, A Danesh, JP Bruce, ... Nature communications 8 (1), 186, 2017 | 94 | 2017 |
| Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition S Lheureux, JP Bruce, JV Burnier, K Karakasis, PA Shaw, BA Clarke, ... Journal of clinical oncology 35 (11), 1240-1249, 2017 | 93 | 2017 |